Verapamil Hydrochloride
- Product NDC
- 60687-493
- 11-digit product format
- 606870493
- Labeler code
- 60687
- Product ID
- 60687-493_e0dda037-e63e-4ab5-e053-2995a90af12d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Verapamil Hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA090700
- Marketing category
- ANDA
- Marketing start
- 2020-06-15
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-493-01 | 60687049301 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-493-01) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (60687-493-11) | 100 blister pack | 2020-06-15 | 0000-00-00 | No | No | Current |